Tevogen Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,283 | 2,331 | 1,135 | 1,318 | 1,052 |
| Receivables | 159 | 159 | 159 | 159 | N/A |
| TOTAL | $2,361 | $3,528 | $2,447 | $2,400 | $1,723 |
| Non-Current Assets | |||||
| PPE Net | 296 | 337 | 378 | 418 | 459 |
| Other Non-Current Assets | 804 | 425 | 486 | 545 | 3,324 |
| TOTAL | $1,101 | $762 | $864 | $964 | $3,783 |
| Total Assets | $3,462 | $4,290 | $3,310 | $3,363 | $5,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,013 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,450 | 6,088 | 6,916 | 5,462 | 3,418 |
| Accrued Expenses | 1,712 | 1,405 | 1,776 | 1,565 | 1,097 |
| TOTAL | $9,043 | $10,416 | $10,612 | $8,938 | $85,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 93 | 64 | 332 | 228 | 14,455 |
| TOTAL | $1,093 | $64 | $332 | $228 | $14,455 |
| Total Liabilities | $10,136 | $10,480 | $10,944 | $9,166 | $99,934 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,678 | 3,501 | 3,413 | 3,322 | 3,292 |
| Common Shares | 0 | 17 | 17 | 17 | 12 |
| Retained earnings | -113,385 | -103,941 | -98,056 | -88,393 | -99,658 |
| TOTAL | $-6,674 | $-6,191 | $-7,634 | $-5,803 | $-94,429 |
| Total Liabilities And Equity | $3,462 | $4,289 | $3,310 | $3,363 | $5,506 |